An analysis of the significant variation in psychostimulant use across the U.S

Farasat Bokhari, Rick Mayes () and Richard Scheffler ()
Additional contact information
Rick Mayes: Department of Political Science, University of Richmond, Richmond
Richard Scheffler: Graduate School of Public Health, University of California, Berkeley, CA

No wp2003_01_01, Working Papers from Department of Economics, Florida State University

Abstract: Objective: To provide a county-level profile of the area variation in psychostimulant use in the U.S. Methods: We sepa-rated 3,030 U.S. counties into two categories of “low” and “high” use of ADHD drugs (based on data from the Drug Enforce-ment Administration, DEA), and then compared them on the basis of their socio-demographic, economic, educational, and medical characteristics. Results: We found that there is a significant difference in the profile of counties that are above or below the national median rate of psychostimulant use (defined as grams/per 100K population). Compared to counties below the median level, counties above the median level have significantly greater population, higher per-capita income, lower unemployment rates, greater HMO penetration, more physicians per capita, and higher students-to-teacher ratios. The two sets of counties also differ significantly in their demographic composition. Conclusions: Our analysis of the DEA's ARCOS data shows that area variation in psychostimulant use is large and growing over time. U.S. counties differ significantly not only in their use of psychostimulant drugs, but also in their socioeconomic, demo-graphic, educational, and health system characteristics.

Keywords: psychostimulants; attention deficit hyperactivity disorder (ADHD); methylphenidate; amphetamine; mental health; children; adolescents (search for similar items in EconPapers)
JEL-codes: I11 (search for similar items in EconPapers)
Pages: 20 Pages
Date: 2003-01, Revised 2004-04
Note: This paper was published in Pharmacoepidemiology and Drug Safety, 2005; 14-4: 267–275 a copy is available from the publisher. If you need a copy of the original working paper, pls. contact the author.
References: Add references at CitEc
Citations:

Published in Pharmacoepidemiology and Drug Safety, 2005; 14-4: 267–275

Downloads: (external link)
http://www3.interscience.wiley.com/cgi-bin/fulltext/109085268/PDFSTART First version, January 2003 (application/pdf)
Our link check indicates that this URL is bad, the error code is: 403 Forbidden (http://www3.interscience.wiley.com/cgi-bin/fulltext/109085268/PDFSTART [301 Moved Permanently]--> https://www3.interscience.wiley.com/cgi-bin/fulltext/109085268/PDFSTART)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:fsu:wpaper:wp2003_01_01

Ordering information: This working paper can be ordered from

Access Statistics for this paper

More papers in Working Papers from Department of Economics, Florida State University Contact information at EDIRC.
Bibliographic data for series maintained by Luke Rodgers ().